Filing Details
- Accession Number:
- 0001246360-13-000515
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-18 16:50:10
- Reporting Period:
- 2013-01-16
- Filing Date:
- 2013-01-18
- Accepted Time:
- 2013-01-18 16:50:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 911326 | Synageva Biopharma Corp | GEVA | Biological Products, (No Disgnostic Substances) (2836) | 561808663 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1277495 | Carsten Boess | 128 Spring Street, Suite 520 Lexington MA 02421 | Svp, Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-01-16 | 9,927 | $1.70 | 9,927 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-01-16 | 9,927 | $49.12 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-01-16 | 9,927 | $0.00 | 9,927 | $1.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 92,659 | 2021-05-25 | No | 4 | M | Direct |
Footnotes
- The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 18, 2012.
- The Stock Option granted the reporting person an option to purchase 158,840 shares of Common Stock (the "Shares"). 25% of the Shares vested and became exercisable on 05/16/2012, and 1/36 of the remainder of the Shares vest and become exercisable monthly thereafter.
Billionaire Hedge Funds
